Actively Recruiting
Comparing TBT to Disorder-Specific Psychotherapy in Veterans With Social Anxiety Disorder
Led by VA Office of Research and Development · Updated on 2026-02-10
264
Participants Needed
1
Research Sites
186 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cognitive behavioral therapy (CBT) is a brief, efficient, and effective treatment for individuals with depressive/anxiety disorders. However, CBT is largely underutilized within the Department of Veterans Affairs due to the cost and burden of trainings necessary to deliver all of the related disorder-specific treatments (DSTs). Transdiagnostic Behavior Therapy (TBT), in contrast, is specifically designed to address numerous distinct disorders within a single protocol in Veterans with depressive/anxiety disorders. The proposed research seeks to evaluate the efficacy of TBT by assessing psychiatric symptomatology and related impairment outcomes in Veterans with social anxiety disorder and comorbid posttraumatic stress via a randomized controlled trial of TBT and an existing DST. Assessments will be completed at pre-, mid-, and post-treatment, and at 6-month follow-up. Process variables also will be investigated.
CONDITIONS
Official Title
Comparing TBT to Disorder-Specific Psychotherapy in Veterans With Social Anxiety Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must be Veterans and registered at Ralph H. Johnson Veterans Affairs Health Care System
- Participants must be clearly competent to provide informed consent for research participation
- Participants must meet DSM-5 criteria for social anxiety disorder
- Participants must have clinically significant symptoms of comorbid posttraumatic stress
You will not qualify if you...
- Recent history (< 2 months) of psychiatric hospitalization or a suicide attempt as documented in their medical record
- Acute, severe illness or medical condition that likely will interfere with study procedures as documented in their medical record
- Recent start of new psychiatric medication(s) (< 4 weeks)
- Primary diagnosis of a condition associated with psychotic symptoms, personality disorder, substance use disorder, or bipolar disorder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ralph H. Johnson VA Medical Center, Charleston, SC
Charleston, South Carolina, United States, 29401-5703
Actively Recruiting
Research Team
D
Daniel F Gros, PhD MA BS
CONTACT
L
Lacey Bonner, MA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here